Clinical Trial

Evaluation of the JUICE HA® as an Anti-sarcopenia

Recruiting
View on ClinicalTrials.gov →
Summary
This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-22; most recent amendment 2026-02-26.
Trial Details
NCT Number NCT06950125
Lead Sponsor China Medical University Hospital
Conditions Sarcopenia in Elderly
Enrollment 60 participants
Start Date 2025-06-23
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-03-13 (estimated)
Updated on ClinicalTrials.gov 2026-02-27